𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduced intravenous glutathione in the treatment of early parkinson's disease

✍ Scribed by Gianpietro Sechi; Maria G. Deledda; Guido Bua; Wanda M. Satta; Giovanni A. Deiana; Giovanni M. Pes; Giulio Rosati

Book ID
117449303
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
667 KB
Volume
20
Category
Article
ISSN
0278-5846

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reply: Intravenous glutathione in Parkin
Reply: Intravenous glutathione in Parkinson's disease
✍ Robert A. Hauser; Kelly E. Lyons πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 273 KB πŸ‘ 1 views

We appreciate the careful reading of our manuscript by Okun and colleagues. 1 However, their letter contains a number of inaccuracies that require correction. We clearly state

Randomized, double-blind, pilot evaluati
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease
✍ Robert A. Hauser; Kelly E. Lyons; Terry McClain; Summer Carter; David Perlmutter πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract The objective of this study was to evaluate the safety, tolerability, and preliminary efficacy of intravenous glutathione in Parkinson's disease (PD) patients. This was a randomized, placebo‐controlled, double‐blind, pilot trial in subjects with PD whose motor symptoms were not adequate